On February 5, 2021, Medifron DBT Co., Ltd. (KOSDAQ:A065650) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,406 KRW | -0.64% | +13.20% | -15.96% |
1st Jan change | Capi. | |
---|---|---|
-15.96% | 73.65M | |
-12.88% | 192B | |
+0.72% | 167B | |
+3.89% | 156B | |
+8.07% | 103B | |
+36.59% | 84.35B | |
+11.25% | 82.24B | |
-6.65% | 71.76B | |
-17.20% | 55.03B | |
-8.73% | 43.53B |
- Stock Market
- Equities
- A057680 Stock
- News T Scientific Co.,Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 14.99999874 billion in funding from T Scientific Co., Ltd.